Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Olema Pharmaceuticals, Inc. (OLMA) had Free Cash Flow per Share of $-0.86 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-43.78M |
|
-- |
|
-- |
|
$47.86M |
|
$-47.86M |
|
$4.08M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-47.86M |
|
$-47.73M |
|
85.50M |
|
85.50M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$367.73M |
|
-- |
|
$14.28M |
|
$382.00M |
|
$33.16M |
|
$3.00M |
|
$3.60M |
|
$36.77M |
|
$345.24M |
|
$345.24M |
|
$345.24M |
|
68.63M |
|
| Cash Flow Statement Financials | |
$-73.86M |
|
$-10.85M |
|
$-2.30M |
|
$139.48M |
|
$52.47M |
|
$-87.01M |
|
$9.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.09 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-73.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.68% |
|
-12.68% |
|
-11.46% |
|
-12.57% |
|
$5.03 |
|
|
Free Cash Flow per Share |
$-0.86 |
$-0.86 |
|